114.14
price down icon1.08%   -1.36
after-market After Hours: 114.14
loading
Abbott Laboratories stock is traded at $114.14, with a volume of 3.60M. It is down -1.08% in the last 24 hours and down -2.18% over the past month. Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
See More
Previous Close:
$115.50
Open:
$115.31
24h Volume:
3.60M
Relative Volume:
0.79
Market Cap:
$199.50B
Revenue:
$41.22B
Net Income/Loss:
$5.77B
P/E Ratio:
38.82
EPS:
2.94
Net Cash Flow:
$6.49B
1W Performance:
-1.48%
1M Performance:
-2.18%
6M Performance:
+7.98%
1Y Performance:
+7.56%
1-Day Range:
Value
$114.01
$115.58
1-Week Range:
Value
$113.85
$116.39
52-Week Range:
Value
$99.71
$121.64

Abbott Laboratories Stock (ABT) Company Profile

Name
Name
Abbott Laboratories
Name
Phone
(224) 667-6100
Name
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Employee
114,000
Name
Twitter
@AbbottNews
Name
Next Earnings Date
2024-10-16
Name
Latest SEC Filings
Name
ABT's Discussions on Twitter

Compare ABT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
ABT
Abbott Laboratories
114.14 199.50B 41.22B 5.77B 6.49B 3.29
Medical Devices icon
SYK
Stryker Corp
376.16 144.82B 21.97B 3.59B 3.21B 9.33
Medical Devices icon
BSX
Boston Scientific Corp
90.55 133.46B 15.91B 1.79B 1.89B 1.21
Medical Devices icon
MDT
Medtronic Plc
82.93 106.63B 33.00B 4.29B 5.50B 3.27
Medical Devices icon
EW
Edwards Lifesciences Corp
73.80 43.59B 6.60B 4.16B 490.10M 6.93

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-08-24 Initiated Oppenheimer Outperform
Sep-19-24 Initiated Piper Sandler Overweight
Jul-30-24 Downgrade Edward Jones Buy → Hold
May-30-24 Initiated Goldman Buy
Jul-21-23 Upgrade Wolfe Research Underperform → Peer Perform
May-30-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-20-23 Reiterated Barclays Overweight
Apr-20-23 Reiterated Bernstein Outperform
Apr-20-23 Reiterated JP Morgan Overweight
Apr-20-23 Reiterated Raymond James Outperform
Apr-20-23 Reiterated UBS Buy
Apr-20-23 Reiterated Wolfe Research Underperform
Mar-29-23 Initiated UBS Buy
Oct-26-22 Initiated Mizuho Neutral
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Hold
Jul-06-22 Initiated Wolfe Research Underperform
Mar-02-22 Resumed BofA Securities Buy
Jan-27-22 Reiterated Credit Suisse Outperform
Jan-27-22 Reiterated Morgan Stanley Overweight
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated UBS Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Oct-27-21 Upgrade Atlantic Equities Neutral → Overweight
Oct-14-21 Initiated Redburn Neutral
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Jan-28-21 Upgrade BTIG Research Neutral → Buy
Sep-11-20 Initiated Wolfe Research Outperform
Jun-01-20 Downgrade Goldman Neutral → Sell
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-02-20 Downgrade Guggenheim Buy → Neutral
Jun-13-19 Reiterated BofA/Merrill Buy
Feb-07-19 Reiterated BofA/Merrill Buy
Jan-02-19 Downgrade Citigroup Neutral → Sell
Nov-30-18 Upgrade Goldman Neutral → Buy
Oct-16-18 Initiated Barclays Overweight
Jun-27-18 Initiated Bernstein Outperform
Jan-30-18 Reiterated Citigroup Neutral
Jan-25-18 Reiterated Stifel Buy
Jan-25-18 Upgrade William Blair Mkt Perform → Outperform
Jan-03-18 Initiated Evercore ISI Outperform
Jan-02-18 Upgrade JP Morgan Neutral → Overweight
Jan-02-18 Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-19-17 Reiterated RBC Capital Mkts Outperform
Oct-19-17 Reiterated Stifel Buy
View All

Abbott Laboratories Stock (ABT) Latest News

pulisher
09:06 AM

Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them - Benzinga

09:06 AM
pulisher
07:57 AM

Teachers Retirement System of The State of Kentucky Purchases 97,343 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

07:57 AM
pulisher
07:47 AM

Toronto Dominion Bank Sells 220,223 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

07:47 AM
pulisher
05:44 AM

Groupama Asset Managment Acquires 41,557 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

05:44 AM
pulisher
03:24 AM

Baby Nutrition Market Size, Growth Status to 2033 Danone, Abbott - openPR

03:24 AM
pulisher
Dec 10, 2024

Lightning Round: Abbott Labs' legal trouble is largely behind it, says Jim Cramer - MSN

Dec 10, 2024
pulisher
Dec 10, 2024

Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch

Dec 10, 2024
pulisher
Dec 10, 2024

In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 - GlobeNewswire Inc.

Dec 10, 2024
pulisher
Dec 10, 2024

Abbott Laboratories (NYSE:ABT) Stock Position Lifted by Geode Capital Management LLC - MarketBeat

Dec 10, 2024
pulisher
Dec 10, 2024

Vestcor Inc Trims Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 10, 2024
pulisher
Dec 10, 2024

Abbott Expands Biowearables for Health and Wellness - The Healthcare Technology Report.

Dec 10, 2024
pulisher
Dec 09, 2024

Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth? - Yahoo Finance

Dec 09, 2024
pulisher
Dec 09, 2024

Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch

Dec 09, 2024
pulisher
Dec 09, 2024

Prostate Cancer Diagnostics Industry Business Report 2024 - GlobeNewswire Inc.

Dec 09, 2024
pulisher
Dec 09, 2024

Diabetes Devices Market Next Big Thing | Major Giants- Abbott Laboratories, Bayer AG, Lifescan - openPR

Dec 09, 2024
pulisher
Dec 09, 2024

Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness - Yahoo Finance

Dec 09, 2024
pulisher
Dec 09, 2024

Y Intercept Hong Kong Ltd Takes $5.49 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 09, 2024
pulisher
Dec 09, 2024

Nomura Asset Management Co. Ltd. Purchases 68,779 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 09, 2024
pulisher
Dec 09, 2024

Medical Nutrition Market Top Companies StudyAbbott - openPR

Dec 09, 2024
pulisher
Dec 08, 2024

First National Bank of Omaha Buys 5,683 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 08, 2024
pulisher
Dec 08, 2024

MML Investors Services LLC Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 08, 2024
pulisher
Dec 07, 2024

Abbott's Big Ten Blood Drive Campaign Saves 60,000 Lives, Awards $1M Health Grant - StockTitan

Dec 07, 2024
pulisher
Dec 07, 2024

Abbott Labs Confirms Justice Department Probe Following Infant Formula Crisis - Main Street Media of Tennessee

Dec 07, 2024
pulisher
Dec 07, 2024

Kovitz Investment Group Partners LLC Buys 76,876 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 07, 2024
pulisher
Dec 07, 2024

Abbott Laboratories (NYSE:ABT) Shares Purchased by Wellington Management Group LLP - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

Abbott Laboratories stock rises Friday, still underperforms market - MarketWatch

Dec 06, 2024
pulisher
Dec 06, 2024

Peering Into Abbott Laboratories's Recent Short Interest - Benzinga

Dec 06, 2024
pulisher
Dec 06, 2024

Malaria Diagnostics Market Overview Report 2024 - GlobeNewswire Inc.

Dec 06, 2024
pulisher
Dec 06, 2024

Worldquant Millennium Advisors LLC Reduces Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Two Sigma Advisers LP Cuts Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Abbott Laboratories (NYSE:ABT) Stock Holdings Reduced by Quadrature Capital Ltd - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Prostate Health Market Overall Study Report 2024-2031 | Abbott - openPR

Dec 06, 2024
pulisher
Dec 05, 2024

Abbott Laboratories (BUE:ABT) 10-Year Sharpe Ratio : 1.12 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 05, 2024

Abbott Accused Of 'Last-Ditch Effort' To Halt Formula Suit - Law360

Dec 05, 2024
pulisher
Dec 05, 2024

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance

Dec 05, 2024
pulisher
Dec 05, 2024

Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch

Dec 05, 2024
pulisher
Dec 05, 2024

January 2025 Options Now Available For Abbott Laboratories (ABT) - Nasdaq

Dec 05, 2024
pulisher
Dec 05, 2024

Brokers Suggest Investing in Abbott (ABT): Read This Before Placing a Bet - Yahoo Finance

Dec 05, 2024
pulisher
Dec 05, 2024

Abbott Laboratories (NYSE:ABT) Position Boosted by Stifel Financial Corp - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

Quantinno Capital Management LP Buys 48,399 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up - Yahoo Finance

Dec 05, 2024
pulisher
Dec 05, 2024

Royal London Asset Management Ltd. Purchases 19,763 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

ABT (Abbott Laboratories) 3-Year EBITDA Growth Rate : 6.80% (As of Sep. 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 05, 2024

Abbott Laboratories (FRA:ABL) EV-to-Revenue : 5.25 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 05, 2024

Abbott Laboratories (FRA:ABL) Price-to-Operating-Cash-Flow : 24.26 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 04, 2024

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - MSN

Dec 04, 2024
pulisher
Dec 04, 2024

IHT Wealth Management LLC Has $5.28 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat

Dec 04, 2024
pulisher
Dec 03, 2024

Abbott's SWOT analysis: stock resilience amid litigation challenges - Investing.com

Dec 03, 2024
pulisher
Dec 03, 2024

Abbott Laboratories (BSP:ABTT34) Financial Strength : 7 (As of Sep. 2024) - GuruFocus.com

Dec 03, 2024
pulisher
Dec 03, 2024

Is Abbott Laboratories Stock Underperforming the Nasdaq? - Nasdaq

Dec 03, 2024
pulisher
Dec 03, 2024

Is Abbott Laboratories Stock Underperforming The Nasdaq? - Barchart

Dec 03, 2024

Abbott Laboratories Stock (ABT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Abbott Laboratories Stock (ABT) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT
Oct 21 '24
Option Exercise
47.00
157,421
7,398,787
342,227
ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT
Oct 21 '24
Sale
117.04
157,421
18,424,298
184,806
medical_devices SYK
$376.16
price down icon 1.75%
medical_devices BSX
$90.55
price up icon 0.39%
medical_devices MDT
$82.93
price down icon 0.78%
medical_devices EW
$73.80
price up icon 0.56%
$82.75
price up icon 0.47%
Cap:     |  Volume (24h):